Clinical Study | Office of Clinical Research

A Phase III Study Of Postoperative Radiation Therapy (Imrt) +/- Cetuximab For Locally-Advanced Resected Head And Neck Cancer

Posted Date: May 15, 2019

Investigator: Jordan Kharofa
Type of Study: Drug

This study will compare the good and bad effects of radiation therapy alone with radiation therapy and cetuximab to find out which is better. Cetuximab is a drug that may delay or prevent tumor growth by blocking certain cellular chemical pathways that lead to tumor development. Follow-up visits wil

Criteria:

Eligible Patients Must Have Head And Neck Cancer That After Surgery Has An Intermediate Risk Of Recu

Keywords:

Head And Neck Cancer, R0920, Recurrent, Resected

For More Information:

Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List